| Date Filed | Type | Description |
| 08/11/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/10/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/10/2023 |
8-K
| Quarterly results |
| 05/11/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 05/11/2023 |
8-K
| Quarterly results |
| 03/30/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/30/2023 |
8-K
| Quarterly results |
| 03/24/2023 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 03/21/2023 |
4
| Braun Donald P (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Chow Pok Yu Augustine (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Fritz Frederick J. (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Pellizzari Christine A (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Dentzer James E (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Lindborg Stacy (Director) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 2,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Tardugno Michael H (Executive Chairman of Board) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 25,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Anwer Khursheed (Chief Scientific Officer) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| CHURCH JEFFREY WAYNE (CFO) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 40,000 options to buy
@ $0 |
|
| 03/21/2023 |
4
| Le Goff Corinne (President and CEO) has filed a Form 4 on Imunon, Inc.|
Txns:
| Granted 90,000 options to buy
@ $0 |
|
| 02/10/2023 |
8-K
| Quarterly results |
| 01/03/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 11/15/2022 |
8-K
| Quarterly results |
| 11/14/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 11/14/2022 |
8-K
| Quarterly results |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 10/03/2022 |
8-K
| Quarterly results |
| 09/19/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ...|
Docs:
|
"CERTIFICATE OF AMENDMENT TO CERTIFICATE OF INCORPORATION OF CELSION CORPORATION Celsion Corporation , a corporation organized and existing under the General Corporation Law of the State of Delaware , does hereby certify that: FIRST: The name of the Corporation is Celsion Corporation. SECOND: The original Certificate of Incorporation of the Corporation Corporation) was filed with the Secretary of State of the State of Delaware on May 17, 2000, a Certificate of Ownership and Merger was thereafter filed with the Secretary of State of the State of Delaware on August 17, 2000, and certificates of Amendment to Certificate of Incorporation were thereafter filed with the Secretary of State of the State of Delaware on June 5, 2001, November 8, 2002, May 25, 2004, February 27, 2006, July 1, 2009, Oc...",
"CERTIFICATE OF ELIMINATION OF SERIES A CONVERTIBLE REDEEMABLE PREFERRED STOCK AND SERIES B CONVERTIBLE REDEEMABLE PREFERRED STOCK OF CELSION CORPORATION Pursuant to Section 151 of the General Corporation Law of the State of Delaware",
"Certificate of Incorporation",
"Celsion Corporation Announces Company Name Change to Imunon, Inc." |
|
| 08/15/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/15/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 08/15/2022 |
8-K
| Quarterly results |
| 07/20/2022 |
4
| Le Goff Corinne (President and CEO) has filed a Form 4 on Celsion CORP|
Txns:
| Granted 53,000 shares
@ $0
Granted 177,000 options to buy
@ $1.95, valued at
$345.2k
|
|
| 07/20/2022 |
3
| Le Goff Corinne (President and CEO) has filed a Form 3 on Celsion CORP |
| 07/19/2022 |
8-K
| Quarterly results |
| 06/15/2022 |
4
| Kardaras Constantine John (Chief Accounting Officer) has filed a Form 4 on Celsion CORP|
Txns:
| Granted 1,750 options to buy
@ $0 |
|
|